seven patients with huntington disease were treated with aminooxyacetic acid ( aoaa ) , an inhibitor of gamma-aminobutyric acid aminotransferase ( gaba-t ) , in an effort to alleviate symptoms by increasing brain gaba content .
C0006104
brain
C0423896
content